Fruit Nutrient May Fight Resistant Prostate Cancer
 (NY, Reuters Health, 1/2/04)

Brad Guess of California, and team, conducted a study sponsored by EcoNugenics, a company that sells MCP, a fruit pectin that has been modified to make it more easily absorbed by the bloodstream. The researchers had 13 men, whose prostate cancer had not responded to surgery and radiation treatments, take 6 capsules of MCP 3 times daily for a year. Three of the subjects dropped out because of mild side-effects, and of the remaining 10, 7 showed a decrease in the aggressiveness of their cancers, as judged by a reduction in the rate of increase of prostate specific antigen (PSA). According to Dr. Stephen Strum of Oregon, study co-author, the MCP may slow the growth and spread of cancer by blocking galectin-3, a surface protein that allows cancer cells to bind together.